Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2012
Epidermal growth factor receptor tyrosine kinase inhibitors beyond progressive disease: a retrospective analysis for Japanese patients with activating EGFR mutationsKenichi Nishie, Tomoya Kawaguchi, Akihiro Tamiya, et al.Medical Oncology (Northwood, London, England)|August 9, 2013
Phase2 study of bevacizumab with carboplatin-paclitaxel for non-small cell lung cancer with malignant pleural effusionMotohiro Tamiya, Akihiro Tamiya, Tadahiro Yamadori, et al.Anticancer Research|October 15, 2013
Carboplatin plus either docetaxel or paclitaxel for Japanese patients with advanced non-small cell lung cancerMasaaki Kawahara, Shinji Atagi, Kiyoshi Komuta, et al.Anticancer Research|July 31, 2012
Efficacy of carboplatin and paclitaxel with bevacizumab as salvage chemotherapy for non-small cell lung cancer after failure of platinum-doublet chemotherapyMotohiro Tamiya, Akihiro Tamiya, Keiko Nakao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2014
Randomized phase III trial of erlotinib versus docetaxel as second- or third-line therapy in patients with advanced non-small-cell lung cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA)Tomoya Kawaguchi, Masahiko Ando, Kazuhiro Asami, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer: results of a west Japan oncology group studyIsamu Okamoto, Hiroshige Yoshioka, Satoshi Morita, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2013
Histology and smoking status predict survival of patients with advanced non-small-cell lung cancer. Results of West Japan Oncology Group (WJOG) Study 3906LYoshihito Kogure, Masahiko Ando, Hideo Saka, et al.The Lancet. Oncology|December 22, 2009
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trialTetsuya Mitsudomi, Satoshi Morita, Yasushi Yatabe, et al.Pageof 3